LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 84.45 | 84.90 | 4704 | 8254 | 0.5699 | 0.8367 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.16 | 84.90 | 623 | 8141 | 0.0765 | 0.3536 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.16 | 84.90 | 4714 | 8141 | 0.5790 | 0.8407 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.16 | 84.90 | 2916 | 8141 | 0.3582 | 0.7112 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.16 | 84.90 | 4822 | 8141 | 0.5922 | 0.8470 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.86 | 84.90 | 611 | 7680 | 0.0796 | 0.3548 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.86 | 84.90 | 4765 | 7680 | 0.6204 | 0.8584 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.86 | 84.90 | 2863 | 7680 | 0.3728 | 0.7183 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.86 | 84.90 | 4892 | 7680 | 0.6370 | 0.8659 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 89.57 | 84.90 | 609 | 7494 | 0.0813 | 0.3564 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 89.57 | 84.90 | 4923 | 7494 | 0.6569 | 0.8741 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 89.57 | 84.90 | 2629 | 7494 | 0.3508 | 0.7008 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 89.57 | 84.90 | 5036 | 7494 | 0.6720 | 0.8807 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 91.27 | 84.90 | 634 | 7420 | 0.0854 | 0.3658 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 91.27 | 84.90 | 5034 | 7420 | 0.6784 | 0.8832 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 91.27 | 84.90 | 2758 | 7420 | 0.3717 | 0.7155 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 91.27 | 84.90 | 5151 | 7420 | 0.6942 | 0.8900 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.98 | 84.90 | 668 | 7257 | 0.0920 | 0.3791 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.98 | 84.90 | 5153 | 7257 | 0.7100 | 0.8961 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.98 | 84.90 | 2952 | 7257 | 0.4067 | 0.7384 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.98 | 84.90 | 5295 | 7257 | 0.7296 | 0.9041 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 84.90 | 705 | 7000 | 0.1007 | 0.3945 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 84.90 | 5232 | 7000 | 0.7474 | 0.9106 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 84.90 | 2563 | 7000 | 0.3661 | 0.7080 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 94.68 | 84.90 | 5389 | 7000 | 0.7698 | 0.9195 | MN20160318_Q02 | K11 |